Abstract
In patients with malaria, the clinical manifestations of the disease are associated with the presence of high concentrations of tumour necrosis factor (TNF) in the serum. Blood-stage parasites of human and rodent malarial parasites release serologically related exoantigens which induce the production of TNF in vitro and in vivo and which can kill mice made hypersensitive to TNF by pretreatment with D-galactosamine. They also elicit the production of T-independent antibody, which blocks these effects. The capacity of the exoantigens to stimulate macrophages to secrete TNF does not require the presence of protein or carbohydrate, but is associated with a lipid whose activity can be abolished by treatment with phospholipase C. Treatments of the exoantigens which destroyed their activity in vitro also abrogated their immunogenicity and their toxicity for mice. No TNF-inducing activity could be detected in preparations of parasitized erythrocytes that was not associated with phospholipid, and the TNF-inducing properties of the malarial phospholipids are quite distinct from those of bacterial lipopolysaccharide. We conclude that release of potentially toxic phospholipids by parasites may be responsible for some of the pathology of malaria.
MeSH Terms
Animals
Antigens, Protozoan/immunology,toxicity
Female
Immune Sera/immunology
Malaria/immunology
Mice
Phospholipids/immunology
Plasmodium yoelii/immunology
Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
Antigens, Protozoan
Immune Sera
Phospholipids
Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bate C A
Department of Immunology, University College & Middlesex School of Medicine, London, U.K.
Taverne J
Román E
Moreno C
Playfair J H
References (24)
24 references, click to expand
-
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.
Immunology. 1990 Jul;70(3):315-20
PMID: 2379940
-
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.
Infect Immun. 1990 Sep;58(9):2923-8
PMID: 2201638
-
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities.
Eur J Biochem. 1985 Apr 1;148(1):1-5
PMID: 2579812
-
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.
Immunology. 1989 Apr;66(4):600-5
PMID: 2654012
-
Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.
Am J Med. 1989 Aug;87(2):139-43
PMID: 2667356
-
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures.
Annu Rev Biochem. 1988;57:285-320
PMID: 3052274
-
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.
J Exp Med. 1988 Mar 1;167(3):752-61
PMID: 3127526
-
Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane.
Infect Immun. 1988 Apr;56(4):903-9
PMID: 3278984
-
Malarial parasites induce TNF production by macrophages.
Immunology. 1988 Jun;64(2):227-31
PMID: 3292408
-
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
J Exp Med. 1987 Mar 1;165(3):657-63
PMID: 3819645
-
A reevaluation of the status of cholesterol in erythrocytes infected by Plasmodium knowlesi and P. falciparum.
Mol Biochem Parasitol. 1984 Sep;13(1):53-65
PMID: 6392884
-
Plasmodium falciparum: an invasion inhibitory human monoclonal antibody is directed against a malarial glycolipid antigen.
Exp Parasitol. 1991 Oct;73(3):317-25
PMID: 1915746
-
Structure, biosynthesis, and function of glycosylphosphatidylinositols.
Biochemistry. 1990 Jun 12;29(23):5413-22
PMID: 2143679
-
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody.
Immunol Lett. 1990 Aug;25(1-3):207-12
PMID: 2283151
-
Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.
Infect Immun. 1990 Oct;58(10):3233-41
PMID: 2401562
-
The malaria vaccine: anti-parasite or anti-disease?
Immunol Today. 1990 Jan;11(1):25-7
PMID: 2405875
-
Tumor necrosis factor and disease severity in children with falciparum malaria.
N Engl J Med. 1989 Jun 15;320(24):1586-91
PMID: 2657427
-
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.
Clin Exp Immunol. 1989 Sep;77(3):361-6
PMID: 2680183
-
Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.
J Immunol. 1988 Feb 15;140(4):1274-9
PMID: 3257774
-
Induction of the proteolytic activity of a membrane protein in Plasmodium falciparum by phosphatidyl inositol-specific phospholipase C.
Nature. 1988 Mar 31;332(6163):457-9
PMID: 3281025
-
Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol.
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8565-9
PMID: 3534892
-
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.
Lancet. 1990 Nov 17;336(8725):1201-4
PMID: 1978068
-
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum.
Parasite Immunol. 1990 Jan;12(1):33-43
PMID: 2179828
-
The leishmanial lipophosphoglycan: a multifunctional molecule.
Exp Parasitol. 1990 Feb;70(2):241-5
PMID: 2404784